国际眼科纵览

• 综述 • 上一篇    下一篇

自噬在眼部疾病中的研究进展

任静 刘静 雯秦波   

  1. 510632 广州,暨南大学(任静、刘静雯);518040 深圳,深圳市眼科医院深圳眼科学重点实验室暨南大学附属深圳眼科医院深圳大学眼视光学院(任静、刘静雯、秦波)
  • 出版日期:2015-10-22 发布日期:2015-10-27
  • 通讯作者: 秦波 E-mail:qinbozf@163.com
  • 基金资助:

    深圳市知识创新计划基础研究项目(JCYJ2015 0402152130696)

Research progress of autophagy in eye diseases

REN Jing1,2, LIU Jing-wen1,2, QIN Bo,2   

  1. 1.Jinan University,Guangzhou 510632, China; 2.Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen Eye Hospital Affiliated to Jinan University, Joint College of Optometry, Shenzhen University, Shenzhen 518040, China
  • Online:2015-10-22 Published:2015-10-27
  • Contact: QIN Bo E-mail:qinbozf@163.com

摘要:

自噬是细胞对不良环境的一种自我防御机制,真核细胞通过自噬清除异常积聚的蛋白和损伤的或多余的细胞器,甚至病原微生物来维持细胞内稳态。近年来的研究表明,自噬与众多眼病包括白内障、角膜营养不良、青光眼、年龄相关性黄斑病变等疾病的发生和发展有着密切联系。期望通过小分子化合物(自噬的激活剂或抑制剂)或者药物调控细胞的自噬水平,从而为眼部疾病提供一种新的治疗策略。(国际眼科纵览,2015,39:309.314)

Abstract:

Autophagy is a kind of cell status with which cells can protect themselves from unfavorable micro-environment. Eukaryotic cells clear accumulation of abnormal proteins, damaged or redundant organelles and microorganisms by autophagy to maintain cellular homeostasis. Increasing evidences had shown that autophagy is closely associated with the pathogenesis and progression of a number of ocular disorders including cataract, corneal dystrophy, glaucoma, age-related macular degeneration and other eye diseases. We expect regulating cell autophagy by small molecular compound (activator or depressor of autophagy) or durg, which will provide new treatment strategies for eye diseases.   (Int Rev Ophthalmol,2015,39:309.314)